The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid

Table 4

Adverse event profile of eicosapentaenoic acid-free fatty acid (EPA-FFA).

	(%)	Frequency
HV
Diarrhoea	1 (6.7)	4
Nausea	2 (13.3)	4
Abdominal pain/distension	2 (13.3)	4
Epigastric discomfort	2 (13.3)	3
Headache	1 (6.7)	3
IBD patients
Diarrhoea	3 (15)	5
Nausea	2 (10)	4
Abdominal pain/distension	3 (15)	5
Epigastric discomfort	3 (15)	3
Headache	2 (10)	4

Frequency is the absolute number of times given adverse events occurred.
HV: healthy volunteers.
IBD: inflammatory bowel disease.